Article
Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer
26 Dec 2018
Abstract excerpt
Abstract Purpose: Serine peptidase inhibitor, Kazal type-1 (SPINK1) overexpression defines the second most recurrent and aggressive prostate cancer subtype. However, the underlying molecular mechanism and pathobiology of SPINK1 in prostate cancer remains largely unknown. Experimental Design: miRNA prediction tools were employed to examine the SPINK1-3′UTR for miRNA binding. Luciferase reporter assays were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
